These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20842140)

  • 1. Circulating tumor cells and melanoma progression.
    Xu X; Zhong JF
    J Invest Dermatol; 2010 Oct; 130(10):2349-51. PubMed ID: 20842140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating melanoma cells as a predictive biomarker.
    Karakousis G; Yang R; Xu X
    J Invest Dermatol; 2013 Jun; 133(6):1460-2. PubMed ID: 23673501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcript-Based Detection of Circulating Melanoma Cells.
    Morici M; Lin W; Gray ES
    Methods Mol Biol; 2021; 2265():235-245. PubMed ID: 33704719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
    De Souza LM; Robertson BM; Robertson GP
    Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
    Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
    J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic model for the analysis of melanoma circulating tumor cells.
    Pícková M; Kahounová Z; Radaszkiewicz T; Procházková J; Fedr R; Nosková M; Radaszkiewicz KA; Ovesná P; Bryja V; Souček K
    Sci Rep; 2024 Apr; 14(1):7827. PubMed ID: 38570556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
    Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
    Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
    Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P
    Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance.
    Khoja L; Lorigan P; Dive C; Keilholz U; Fusi A
    Ann Oncol; 2015 Jan; 26(1):33-39. PubMed ID: 24907634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
    Yanagita M; Luke JJ; Hodi FS; Jänne PA; Paweletz CP
    Melanoma Res; 2018 Apr; 28(2):89-95. PubMed ID: 29406397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
    Lucci A; Hall CS; Patel SP; Narendran B; Bauldry JB; Royal RE; Karhade M; Upshaw JR; Wargo JA; Glitza IC; Wong MKK; Amaria RN; Tawbi HA; Diab A; Davies MA; Gershenwald JE; Lee JE; Hwu P; Ross MI
    Clin Cancer Res; 2020 Apr; 26(8):1886-1895. PubMed ID: 32015020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
    De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
    J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free high-throughput photoacoustic tomography of suspected circulating melanoma tumor cells in patients in vivo.
    Hai P; Qu Y; Li Y; Zhu L; Shmuylovich L; Cornelius LA; Wang LV
    J Biomed Opt; 2020 Mar; 25(3):1-17. PubMed ID: 32170857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
    Ireland A; Millward M; Pearce R; Lee M; Ziman M
    Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China.
    Li J; Fu W; Zhang W; Li P
    Med Sci Monit; 2018 Jan; 24():324-331. PubMed ID: 29337932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers.
    Nedosekin DA; Sarimollaoglu M; Ye JH; Galanzha EI; Zharov VP
    Cytometry A; 2011 Oct; 79(10):825-33. PubMed ID: 21786417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
    Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
    J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capture and Isolation of Circulating Melanoma Cells Using Photoacoustic Flowmetry.
    Edgar RH; Cook J; Douglas M; Samson AP; Viator JA
    Methods Mol Biol; 2021; 2265():203-212. PubMed ID: 33704716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells in Stage IV Melanoma Patients.
    Hall CS; Ross M; Bowman Bauldry JB; Upshaw J; Karhade MG; Royal R; Patel S; Lucci A
    J Am Coll Surg; 2018 Jul; 227(1):116-124. PubMed ID: 29746918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.